These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23757341)

  • 41. Assessment of Key Elements in the Innate Immunity System Among Patients with HIV, HCV, and Coinfections of HIV/HCV.
    Moradi M; Tabibzadeh A; Javanmard D; Ghorbani S; Bokharaei-Salim F; Keivani H; Khazeni M; Monavari SHR
    Curr HIV Res; 2020; 18(3):194-200. PubMed ID: 32209045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role for plasmacytoid dendritic cells in anti-HIV innate immunity.
    Müller-Trutwin M; Hosmalin A
    Immunol Cell Biol; 2005 Oct; 83(5):578-83. PubMed ID: 16174110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasmacytoid dendritic cell and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in chronically suppressed HIV-1(+) patients.
    Papasavvas E; Foulkes A; Yin X; Joseph J; Ross B; Azzoni L; Kostman JR; Mounzer K; Shull J; Montaner LJ
    Immunology; 2015 Jul; 145(3):380-90. PubMed ID: 25684333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. B and T lymphocyte attenuator down-regulation by HIV-1 depends on type I interferon and contributes to T-cell hyperactivation.
    Zhang Z; Xu X; Lu J; Zhang S; Gu L; Fu J; Jin L; Li H; Zhao M; Zhang J; Wu H; Su L; Fu YX; Wang FS
    J Infect Dis; 2011 Jun; 203(11):1668-78. PubMed ID: 21592997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection.
    Fan Z; Huang XL; Kalinski P; Young S; Rinaldo CR
    Clin Vaccine Immunol; 2007 Sep; 14(9):1127-37. PubMed ID: 17634507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals.
    Van Gulck ER; Vanham G; Heyndrickx L; Coppens S; Vereecken K; Atkinson D; Florence E; Kint I; Berneman ZN; Van Tendeloo V
    J Virol; 2008 Apr; 82(7):3561-73. PubMed ID: 18234800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interferon-alpha administration enhances CD8+ T cell activation in HIV infection.
    Manion M; Rodriguez B; Medvik K; Hardy G; Harding CV; Schooley RT; Pollard R; Asmuth D; Murphy R; Barker E; Brady KE; Landay A; Funderburg N; Sieg SF; Lederman MM
    PLoS One; 2012; 7(1):e30306. PubMed ID: 22291932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers.
    Hardy GA; Sieg S; Rodriguez B; Anthony D; Asaad R; Jiang W; Mudd J; Schacker T; Funderburg NT; Pilch-Cooper HA; Debernardo R; Rabin RL; Lederman MM; Harding CV
    PLoS One; 2013; 8(2):e56527. PubMed ID: 23437155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neisseria gonorrhoeae effectively blocks HIV-1 replication by eliciting a potent TLR9-dependent interferon-α response from plasmacytoid dendritic cells.
    Dobson-Belaire WN; Rebbapragada A; Malott RJ; Yue FY; Kovacs C; Kaul R; Ostrowski MA; Gray-Owen SD
    Cell Microbiol; 2010 Dec; 12(12):1703-17. PubMed ID: 20735437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Higher homologous and lower cross-reactive Gag-specific T-cell responses in human immunodeficiency virus type 2 (HIV-2) than in HIV-1 infection.
    Jennes W; Camara M; Dièye T; Mboup S; Kestens L
    J Virol; 2008 Sep; 82(17):8619-28. PubMed ID: 18562522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific immune response to human immunodeficiency virus (HIV)-1 in patients assessed through the production of interferon-gamma and interleukin-4 in HIV-1 p24-activated whole blood cultures: relationship with the viral load in plasma.
    Hober D; Benyoucef S; Chieux V; De Groote D; De La Tribonnière X; Bocket L; Lion G; Mouton Y; Wattré P
    Scand J Immunol; 1999 Jul; 50(1):83-90. PubMed ID: 10404056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Up-regulation of TLR2 and TLR4 in dendritic cells in response to HIV type 1 and coinfection with opportunistic pathogens.
    Hernández JC; Arteaga J; Paul S; Kumar A; Latz E; Urcuqui-Inchima S
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1099-109. PubMed ID: 21406030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapy.
    Usuga X; Montoya CJ; Landay AL; Rugeles MT
    J Acquir Immune Defic Syndr; 2008 Dec; 49(4):348-57. PubMed ID: 19186348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.
    Gonzalez VD; Landay AL; Sandberg JK
    Clin Immunol; 2010 Apr; 135(1):12-25. PubMed ID: 20100670
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV-1 Is a Poor Inducer of Innate Immune Responses.
    Cingöz O; Goff SP
    mBio; 2019 Feb; 10(1):. PubMed ID: 30755516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV-1 and HIV-2 differentially mature plasmacytoid dendritic cells into IFN-producing cells or APCs.
    Royle CM; Graham DR; Sharma S; Fuchs D; Boasso A
    J Immunol; 2014 Oct; 193(7):3538-48. PubMed ID: 25156368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alpha interferon and HIV infection cause activation of human T cells in NSG-BLT mice.
    Long BR; Stoddart CA
    J Virol; 2012 Mar; 86(6):3327-36. PubMed ID: 22238321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distinctive TLR7 signaling, type I IFN production, and attenuated innate and adaptive immune responses to yellow fever virus in a primate reservoir host.
    Mandl JN; Akondy R; Lawson B; Kozyr N; Staprans SI; Ahmed R; Feinberg MB
    J Immunol; 2011 Jun; 186(11):6406-16. PubMed ID: 21515797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disruption of Type I Interferon Induction by HIV Infection of T Cells.
    Sanchez DJ; Miranda D; Marsden MD; Dizon TM; Bontemps JR; Davila SJ; Del Mundo LE; Ha T; Senaati A; Zack JA; Cheng G
    PLoS One; 2015; 10(9):e0137951. PubMed ID: 26375588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasmacytoid dendritic cells (pDCs) from HIV controllers produce interferon-α and differentiate into functional killer pDCs under HIV activation.
    Barblu L; Machmach K; Gras C; Delfraissy JF; Boufassa F; Leal M; Ruiz-Mateos E; Lambotte O; Herbeuval JP;
    J Infect Dis; 2012 Sep; 206(5):790-801. PubMed ID: 22693234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.